Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · Real-Time Price · USD
2.290
+0.070 (3.15%)
Nov 21, 2024, 2:47 PM EST - Market open
Aadi Bioscience Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 56 | 50 | 313 | 505 | - | - |
| Market Cap Growth | -57.27% | -84.17% | -37.97% | - | - | - |
| Enterprise Value | -7 | -68 | 132 | 344 | - | - |
| Last Close Price | 2.22 | 2.02 | 12.83 | 24.15 | - | - |
| PS Ratio | 2.39 | 2.03 | 20.57 | 450.53 | - | - |
| PB Ratio | 0.79 | 0.47 | 1.98 | 3.70 | - | - |
| P/TBV Ratio | 0.74 | 0.47 | 1.98 | 3.81 | - | - |
| EV/Sales Ratio | - | - | 8.66 | 306.99 | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | -0.82 | -0.93 |
| Asset Turnover | 0.22 | 0.15 | 0.09 | 0.01 | 0.82 | - |
| Inventory Turnover | 11.58 | 12.49 | - | - | - | - |
| Quick Ratio | 4.37 | 4.33 | 9.26 | 9.76 | 0.62 | 0.63 |
| Current Ratio | 4.89 | 4.72 | 9.56 | 9.90 | 0.62 | 0.64 |
| Return on Equity (ROE) | -65.95% | -49.90% | -41.06% | -177.60% | - | - |
| Return on Assets (ROA) | -35.27% | -28.40% | -21.54% | -26.21% | -8.98% | - |
| Return on Capital (ROIC) | -41.97% | -33.74% | -24.81% | -34.36% | - | - |
| Earnings Yield | -112.74% | -132.75% | -19.33% | -21.82% | - | - |
| FCF Yield | -103.12% | -128.45% | -16.00% | -4.45% | - | - |
| Buyback Yield / Dilution | -0.38% | -19.58% | -152.27% | -250.99% | 68.28% | - |
| Total Shareholder Return | -0.38% | -19.58% | -152.27% | -250.99% | 68.28% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.